WeightWatchers going into prescription weight loss business with telehealth provider acquisition

WeightWatchers' stock soared on Tuesday after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence. Sequence is a telehealth provider that offers users access to drugs used to treat diabetes and obesity under such brand names as Ozempic, Wegovy and Trulicity.